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Background: This in vitro study was carried out to screen the aqueous extracts of selected local plants 
(clinacanthus nutans, strobilanther crispa and pereskia bleo) known locally to possess anticancer 
properties for cytotoxic activity.  Method: The antiproliferative activity on human oral squamous cell 
carcinoma, ORL-48 was assessed based on a colorimetric assay using neutral red dye. Result: 
Clinacanthus nutans exhibited an IC50 of 49.8 ± 0.02 µg/mL on ORL-48 cells, while Strobilanther crispa 
and Pereskia bleo showed no antiproliferative response. Conclusion: The aqueous extract of clinacanthus 
nutans, strobilanther crispa and pereskia bleo does not possess anti proliferative activity towards oral 
squamous carcinoma cells ORL-48.  
1. Introduction 
Cancer therapies that utilizing the natural products is a 
promising approach where it suppresses, delay, reverse, 
or retard the process of carcinogenesis.1 However, 
shifting from conventional therapy towards herbal cure 
would require empirical evidence with regards to 
efficacy and safety.2 
In Malaysia the practice of traditional medicine is still 
very significant as many still rely on traditional 
preparations to heal various ailments. Cancer is readily 
perceived by the lay man to be associated with tumour 
and to the understanding of many tumours needs to be 
removed through surgical procedures. In order to avoid 
going through such invasive procedures, many have turn 
to alternative medicines to control and heal the disease.  
Many plants from the tropical rain forest Malaysia have 
been used as traditional medicines to prevent and treat 
various types of cancers. Clinacanthus nutans (Belalai 
gajah), strobilanther crispa (Pecah beling) and pereskia 
bleo (Jarum tujuh bilah) are three plants traditionally 
used as cancer treatment and consumed in the form of 
decoction. Despite the availability of numerous 
anecdotal reports, evaluation of active anticancer effects 
has remained elusive. Therefore, this preliminary study 
was conducted to determine the antiproliferative activity 
of this plants. 
 
2. Materials and Method 
Oral cancer cell lines 
Human oral squamous cell carcinoma (OSCC) cell line 
was used in the study. ORL-48 obtained from the Cancer 
Research Institute and Foundation, Subang Jaya Medical 
Centre (CARIF, Malaysia) was developed from a female 
patient with gum tumour. The cell line was cultured in 
DMEM F-12 medium (GibcoUSA) supplemented with 
10% fetal bovine serum, 2 mL of penicillin-streptomycin 
and 1 mL of amphotericin B.  Cell lines were incubated 
at 37°C in a humidified atmosphere containing 5% CO2 
(Thermo Forma).  
Extracts preparation 
The leaves of the plants were collected from Taman 
Botani Rimba Ilmu, University Malaya. The leaves were 
cleaned and dried. The leaves were then weighed and cut 
into small pieces before they were boiled in distilled 
water for several hours until the final volume is one third 
of the initial volume. The decoction obtained were 
centrifuged at 10,000 rpm to eliminate sediments. The 
decoction was concentrated and freeze-dried (EYELA 
FDU-1200, Tokyo) for use in the study. 
Antiproliferative Assay 
The antiproliferative activity of the extracts on ORL-48 
cell lines was assessed based on a colorimetric assay 
using neutral red dye described in Zabidi et al.3 The 
ORL-48 cells were seeded at 3 x 104 cells/mL in 96-well 
plates (Nunc, Germany). A 20 mg/mL stock extract of 
each plants was prepared using sterile distilled water 
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were diluted to varying concentrations of 0.1, 1.0, 2.5, 
5.0, 7.5 and 10.0 µg/mL in separate wells using DMEM 
F-12 containing 10% fetal bovine serum, 1% penicillin-
streptomycin, and amphotericin B. The cultures were 
incubated in a humidified incubator over a period of 72 
hrs at 37 °C and 5% CO2 (Thermo Forma, USA). Wells 
containing cells in the absence of the agents represented 
the negative control for the test. Following incubation, 
the culture medium was discarded and replaced with 100 
𝜇L neutral red (1% v/v). The culture plates were further 
incubated for 2 hours after which the cells were washed 
with 1 mL of solution containing 1% sodium dodecyl 
sulfate. The culture plates were placed on a rocker (Nunc, 
Germany) for 30 min and the density of the detached 
viable cells that absorbed the red dye was assessed based 
on the optical absorbance read using an ELISA 
microplate reader (Bio Tek, USA) at a wavelength of 
540 nm. The concentration of extract causing 50% of 
cell death known as the inhibition concentration (IC50) 
was determined by a graph of percentage of cell death 
versus concentrations of the plant extracts. Percentage of 
inhibition at every treatment concentration was 
calculated using formula stated below.  
% of Inhibition = (OD control – OD sample) x 100                                                                                            
                                      OD control                                                                                    
3. Result 
Clinacanthus nutans exhibited an IC50 of 49.8 ± 0.02 
µg/mL on ORL-48 cells.  The extracts of Strobilanther 
crispa and Pereskia bleo were found not cytotoxic with 
non-determinable (ND) IC50 values.    
Table 1. Cytotoxic activity of extracts on oral mucosal cancer 
cell line ORL-48 measured by the concentration required to 
inhibit 50% of cell proliferation (IC50). 
Treatment IC50 (µg/mL) 
Clinacanthus nutans 49.8 ± 0.02 
Strobilanther crispa ND 
Pereskia bleo ND 
4. Discussion 
Screening of plant extracts for anti-proliferative activity 
was based on their IC50 towards ORL-48 cells. The 
neutral red cytotoxicity assay described by Zabidi et al.3 
was used to determine the IC50 of the extracts in causing 
50 % cell inhibition. According to the standard National 
Cancer Institute criteria 4,5 crude extracts possessing an 
IC50 less than 20 μg/ml are considered active against the 
tested cancer cells. Thus, the aqueous extract of 
Clinacanthus nutans was not antiproliferative towards 
Human OSCC cell line with an IC50 >20 μg/ml, in 
agreement with Yong et al.6 that reported poor 
antiproliferative effect of the methanol and water 
extracts of Clinacanthus nutans. Strobilanther crispa 
and Pereskia bleo were non-determinable (ND) because 
it does not reach 50% cell inhibition. Therefore, no value 
can be recorded. 
Point that needs to be considered in work involving plant 
is the technique employed in the preparation of the 
compounds. The type of solvent used in the preparation 
is important as that will determine whether the 
compounds extracted from the plants are polar or non-
polar. In this study, the preparation technique used was 
by aqueous extraction. This was based on the 
understanding that medicinal plants are often boiled, and 
the concentrates are then directly consumed by the 
patients. In other words, by simple boiling, whatever 
active compounds that were extracted from the plants 
have to be polar components which when consumed 
would be easily dissolved and absorbed by the body 
system. 
 5. Conclusion 
Based on our findings, the polar compound extracted 
from aqueous extracts of clinacanthus nutans, 
strobilanther crispa and pereskia bleo does not have 
antiproliferative activities towards human OSCC cell 
line. 
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